検索結果

Over-The-Counter Medicines | Business Activities | About Senju | SENJU Pharmaceutical

ups. Notable among these is our leading line of Mytear artificial tear-type eye drops, Japan's first such product and one of the most respected brands in the OTC field. We have also devoted our e...

产品开发方针 | 研究与开发 | 千寿制药株式会社

而其中10亿人以上未得到必要的治疗。并且报告中还提到白内障、屈光不正（近视、老花眼等）、老年性黄斑变性、青光眼、糖尿病性视网膜病变等是导致全球性视力受损或失明的主要原因。 为创造针对眼部疾病的高价值（First in Class、Best in Class、提升患者便利性等）的产品，今后，我们也将全力推进研究开发活动。我们从“对导致视力受损或失明的眼部疾病的贡献”、“满足未满足的医疗需求*”、“商...

einafter this "Product") from Ministry of Health, Labour and Welfare. This Product is the first eye drop in Japan containing “Brimonidine tartrate”, an ingredient that relieves hyperemia and...

临床试验信息 | 研究与开发 | 千寿制药株式会社

List of Clinical Trial Summaries ※Listed in order of date of first publication Medical Condition Phase Project Code Country Recruitment Status Access to Trial ID Allergic Conjunctivitis 2 SJP-0049 Jap...

pects. Adv Exp Med Biol. 2021;1256:1-31. 5 Colijn JM, et al. Enlargement of Geographic Atrophy From First Diagnosis to End of Life. JAMA Ophthalmol. 2021 Jul 1;139(7):743-750. 6 IZERVAY™ (avancincapta...